Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Robert L. Dixon, Jr. net worth and biography

Robert Dixon, Jr. Biography and Net Worth

Director of Elevance Health

Robert L. Dixon Jr. serves as Independent Director of the Company. Mr. Dixon joined our board in June 2019. Mr. Dixon has owned The RD Factor, Inc., a digital and information technology consulting business, since December 2016. Mr. Dixon served at PepsiCo, Inc., a global food and beverage company, as Global Chief Information Officer and Senior Vice President from 2007 through 2016. Previously, Mr. Dixon held various positions with The Procter & Gamble Company, a consumer household products company, since 1977, including Vice President of Global Business Services. Mr. Dixon has served on the boards of Anthem, Inc., a health benefits company, since 2011, and Build-A-Bear Workshop, Inc., a specialty retailer, since February 2018. At the Georgia Institute of Technology, Mr. Dixon serves on the President’s Advisory Board, the College of Engineering Advisory Board and the College of Computing Advisory Board. He previously served on the CIO Advisory Board for IBM. Mr. Dixon holds a Bachelor of Science Degree in electrical engineering from The Georgia Institute of Technology.

What is Robert L. Dixon, Jr.'s net worth?: The estimated net worth of Robert L. Dixon, Jr. is at least $24.06 million as of September 1st, 2023. Mr. Dixon, Jr. owns 44,980 shares of Elevance Health stock worth more than $24,062,051 as of April 19th. This net worth estimate does not reflect any other investments that Mr. Dixon, Jr. may own. Learn More about Robert L. Dixon, Jr.'s net worth.
How do I contact Robert L. Dixon, Jr.?: The corporate mailing address for Mr. Dixon, Jr. and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on Robert L. Dixon, Jr.'s contact information.
Has Robert L. Dixon, Jr. been buying or selling shares of Elevance Health?: Robert L. Dixon, Jr. has not been actively trading shares of Elevance Health during the last ninety days. Most recently, Robert L. Dixon, Jr. sold 310 shares of the business's stock in a transaction on Friday, July 21st. The shares were sold at an average price of $476.71, for a transaction totalling $147,780.10. Following the completion of the sale, the director now directly owns 9,638 shares of the company's stock, valued at $4,594,530.98. Learn More on Robert L. Dixon, Jr.'s trading history.
Who are Elevance Health's active insiders?: Elevance Health's insider roster includes Gail Boudreaux (CEO), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.
Are insiders buying or selling shares of Elevance Health?: In the last year, insiders at the sold shares 3 times. They sold a total of 1,127 shares worth more than $553,358.50. The most recent insider tranaction occured on February, 7th when Director Ramiro G Peru sold 753 shares worth more than $376,500.00. Insiders at Elevance Health own 0.4% of the company. Learn More about insider trades at Elevance Health.
Information on this page was last updated on 2/7/2024.

Robert L. Dixon, Jr. Insider Trading History at Elevance Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/21/2023	Sell	310	$476.71	$147,780.10	9,638
6/6/2022	Sell	420	$497.14	$208,798.80	9,491
5/27/2020	Sell	1,102	$284.59	$313,618.18	9,568
7/26/2019	Sell	520	$294.11	$152,937.20	9,971
5/18/2018	Sell	1,000	$231.10	$231,100.00

Robert L. Dixon, Jr. Buying and Selling Activity at Elevance Health

Elevance Health Company Overview

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Today's Range

Now: $531.59

$525.90

$536.02

50 Day Range

MA: $508.63

$497.60

$525.19

2 Week Range

Now: $531.59

$412.00

$539.11

Volume

1,791,392 shs

Average Volume

1,063,187 shs

Market Capitalization

$123.70 billion

P/E Ratio

21.12

Dividend Yield

1.28%

Beta

0.78

Tiny Biotech Stock Wins $75 Billion Patent

From Behind the Markets | Ad

Find out more here >>>